Adalvo signs licence deal with EQL Pharma for Mellozzan
Pharmaceutical Technology
MAY 25, 2023
Adalvo has entered a strategic licensing agreement with Swiss pharmaceutical company EQL Pharma for Mellozzan (melatonin) outside Europe and the US. With a network of more than 134 local pharmaceutical companies, Adalvo supplies more than 110 different medicines in over 100 countries across the world.
Let's personalize your content